Monday, September 23, 2019
- 1:45pm-3:15pm
-
Clinical and cognitive features of anxiety in Parkinson’s disease
Psychiatric Manifestations · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Clinical and fMRI effects of Action Observation and Motor Imagery Training on dual-task performances in Parkinson’s disease patients with postural instability and gait disorders
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Clinical and genetic features of paroxysmal kinesigenic dyskinesia (PKD) studied with whole exome sequencing (WES)
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Clinical and genetic heterogeneity in Indian subcontinent patients with Autosomal Dominant Spinocerebellar Ataxia 42
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Clinical and molecular features of a Chinese family with spinocerebellar ataxia type 6
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Clinical Audit of Hospital Admissions for Parkinson Disease
Other · Agora 2 West, Level 2
- 1:45pm-3:15pm
-
Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study
Other · Agora 2 West, Level 2
- 1:45pm-3:15pm
-
Clinical hypnosis in functional movement disorders: a potential therapeutic strategy
Functional (Psychogenic) Movement Disorders · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Clinical outcome in early-treated Sepiapterine Reductase Deficiency (SRD): A case report
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Clinical spectrum of Functional Movement Disorders: A clinic based study from a developing country
Functional (Psychogenic) Movement Disorders · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 75
- Next Page»